Navigation Links
Clinical Gastroenterology and Hepatology most influential journal in field of clinical medicine
Date:1/21/2009

Bethesda, MD (Jan. 15, 2009) The American Gastroenterological Association (AGA) Institute journal, Clinical Gastroenterology and Hepatology, is the medical journal with the most impact on the field of clinical medicine, according to a recent analysis of Essential Science Indicators data by Thompson Reuters. This impact was measured by the greatest percentage increase in citations for any clinical medical journal. The current citation record for Clinical Gastroenterology and Hepatology (CGH) includes 653 papers cited more than 4,400 times between Jan. 1, 1998 and Aug. 31, 2008.

"Clinical Gastroenterology and Hepatology is a unique journal that helps practicing gastroenterologists better treat their patients based on the newest published data," said C. Mel Wilcox, MD, MSPH, editor-in-chief. "Coming so soon after the announcement of CGH's high impact factor, we are pleased that the data being published in the AGA Institute clinical journal is so well-received by its audience in the clinical care community."

CGH was launched in 2001 as a clinical journal for gastroenterologists. CGH publishes research that is immediately applicable to practicing physicians and can be used in the clinic or for teaching. CGH has a prestigious board of editors, led by Dr. Wilcox, and has an international reviewer base. Studies submitted to CGH undergo a rigorous peer-review process, therefore, only the highest quality content is accepted for publication. In 2008, CGH received its first impact factor after only five years of publication, CGH received a remarkable score of 5.465, debuting at a rank of eight out of 50 gastroenterology- and hepatology-related journals. The impact factor is a measure of how often papers are cited in the medical literature.

Thompson Reuters is a source of industry expertise and innovative technology. The scientific division of Thompson Reuters delivers
'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making
2. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
3. New criteria for measuring tumor size and progression will help ease workloads in clinical trials
4. NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase(R)) and Strengthens Clinical Leadership
5. The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance
6. Tomball Regional Medical Center Selects Clinical Xpert(TM) from Thomson Reuters to Lead Quality Improvement Initiatives
7. ClearTrial to Provide Guidelines for Accurately Forecasting and Budgeting Adaptive Clinical Trials at CBI Conference
8. Video: Supermodel Kim Alexis Joins Forces with the American Association of Clinical Endocrinologists in a National PSA to Raise Awareness About Thyroid Problems
9. OpusMobility(R) Clinical Information System Runs on Google G1 Smart Phone
10. Annual SNM MI summit introduces the clinical trials network
11. InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Angeles, CA (PRWEB) September 02, 2014 ... article on its website titled “Why You Should Wash ... than 80 percent of the global population breathes air ... and particles of pollution lodge in the skin’s pores ... body’s natural barrier to free radicals that may cause ...
(Date:9/2/2014)... groundwork for their own spread throughout the body by ... signals, according to a new report by Johns Hopkins ... Nature Communications , the researchers describe animal and ... molecules released by breast cancer cells. These molecules cause ... nodes to produce proteins called CCL5 and VEGF. CCL5 ...
(Date:9/2/2014)... By Kathleen Doheny ... -- The U.S. obesity epidemic is a driving force behind ... new study. Researchers looked at data from five national ... the increase in diabetes over time could be explained by ... in U.S. adults. The investigators found that the prevalence ...
(Date:9/2/2014)... News) -- A leading group of oncologists has released ... of advanced breast cancer. HER2-negative breast tumors ... the HER2 protein, the American Society of Clinical Oncology ... Almost 80 percent of women with advanced breast cancer ... this guideline, our aim is to improve both the ...
(Date:9/2/2014)... research on sleep apnea, tonsillectomies, hearing loss, head ... be presented in Orlando, FL, September 21-24, at ... the American Academy of OtolaryngologyHead and Neck Surgery ... nose, throat, head and neck physicians in the ... presented were released today, and are available online ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:New Guidelines for Treating Form of Advanced Breast Cancer 2
... women with a common thyroid problem may have a ... ,Studies in the past have shown that one of ... Although animal studies found mammary gland cells responded to ... in the relationship between thyroid hormone and breast cancer. ...
... allergen found in the air in many inner-city homes ... in children say researchers. ,According to researchers children ... allergy-causing substance found in mouse urine that is circulating ... developing allergic sensitivity to mice, just as it does ...
... live their lives by their sports drinks and energy drinks ... athletic achievements. //According to a study published in the January ... dental enamel is caused by bottled lemonade, sports drinks and ... enamel by these drinks are as much as 11 times ...
... there are actually scientific reasons why children may be ... strong // sweet tooth. Researchers found variation in a ... and adults. Age and culture also contribute to taste ... the study researchers compared taste sensitivity and food-related behaviors ...
... to evaluate the effect of diseases on contact with children ... were less likely to get the kind of affection other ... HIV-positive parents report avoided certain types of physical contact with ... to their children or pick up infections from the kids ...
... gum disease are more likely to suffer from atherosclerosis, or ... attack // or stroke shows latest research . ... mouths of 657 people who had no history of heart ... used to identify atherosclerosis, was also measured. People with a ...
Cached Medicine News:
(Date:9/2/2014)... , Sept. 2, 2014  XBiotech announced ... study being conducted in the US for its ... Human™ monoclonal antibody therapy, is being evaluated in ... complicated with cachexia. The primary endpoint of the ... treated patients to a control population provided only ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com announces ... in its catalogue: Acute Heart Failure ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute Heart ... Summary GlobalData,s clinical trial report, "Acute ... provides data on the Acute Heart Failure clinical ...
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
Breaking Medicine Technology:XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... 27 Tengion, Inc. (Nasdaq: TNGN ), ... its first Analyst and Investor Meeting which was held ... and discussions of milestones and key data for the ... archive of the event and presentation materials will be ...
... DEL REY, Calif., Oct. 27 Prostate Oncology Specialists, ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 2Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 3Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 4Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 5Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 2Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 3Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 4
...
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: